Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Development of Novel Second Generation DC/Tumor Fusion Vaccine in Lymphoma

Shira Orr, PhD, Marzia Capelletti, PhD MBBS, Haider Ghiasuddin, Dina Stroopinsky, PhD, Jessica Liegel, MD, Myrna Nahas, MD, Matthew Weinstock, MD, Adam Morin, Robin M. Joyce, MD, Salvia Jain, MD, Jon E. Arnason, MD, Maryam Rahimian, MD, Lina Bisharat, Shufen Meng, MD, Donald Kufe, MD, Jacalyn Rosenblatt, MD, David E. Avigan, MD

Blood (2019) 134 (Supplement_1): 392.

https://doi.org/10.1182/blood-2019-124768

Published: 2019

Journal Articles

Primary Diffuse Large B-Cell CNS Lymphoma over 80 Years: An Analysis of 110 Patients from the French Oculo-Cerebral Lymphoma (LOC) Network

Blood (2018) 132 (Supplement 1): 4206.

https://doi.org/10.1182/blood-2018-99-117331

Published: 2018

Journal Articles

Bilateral, Simultaneous Total Knee Replacement (TKR) Surgery for Hemophilia a with Eloctate (Extended Half Life Product)—A Feasible and Cost Effective Approach

Shashikant Apte, MD FRCPA, Rajesh Phatale, MD, Aditi Joshi, BAMS, Kannan Subramanian, MD DM, MBBS

Blood (2018) 132 (Supplement 1): 4684.

https://doi.org/10.1182/blood-2018-99-116160

Published: 2018

Journal Articles

Platelets Promote Activation of the Complement System in Ovarian Cancer

Omayra Gonzalez Pagan, MD, Min Soon Cho, PhD, Vahid Afshar-Kharghan, MD

Blood (2018) 132 (Supplement 1): 4970.

https://doi.org/10.1182/blood-2018-99-116752

Published: 2018

Journal Articles

The French LOC Network for Primary CNS Lymphoma (PCNSL) Patients: What Can We Learn from a Large National Database?

Blood (2016) 128 (22): 926.

https://doi.org/10.1182/blood.V128.22.926.926

Published: 2016

Journal Articles

First Report on the Safety and Efficacy of a Long-Acting Recombinant FVIII (turoctocog alfa pegol, N8-GP) during Major Surgery in Patients with Severe Hemophilia a

Kingsley Hampton, Pratima Chowdary, Scott Dunkley, Silke Ehrenforth, MD PhD, Lotte Jacobsen, Anne T. Neff, MD, Elena Santagostino, MD PhD, Jameela Sathar, Hideyuki Takedani, Clifford M. Takemoto, MD, Claude Négrier

Blood (2015) 126 (23): 2283.

https://doi.org/10.1182/blood.V126.23.2283.2283

Published: 2015

Journal Articles

Levels of Circulating Alternatively Spliced Tissue Factor (asTF) in the Plasma of Patients with Pancreatic Ductal Adenocarcinoma (PDAC) May Help Predict Aggressive Tumor Phenotype

Dusten Unruh, BS, Farah Sagin, BA, Mariette Adam, Patrick Van Dreden, PhD, Barry J Woodhams, PhD, Syed A Ahmad, MD, Vladimir Y Bogdanov, PhD

Blood (2014) 124 (21): 1486.

https://doi.org/10.1182/blood.V124.21.1486.1486

Published: 2014

Journal Articles

Erythrocytosis and Normal Erythropoietin Levels In a 3 Year Old Female With High-Risk Neuroblastoma

Erin Kelly Barr, MA, MD, Mary Elizabeth Ross, MD, PhD, Mohamad M. Al-Rahawan, MD, MPH

Blood (2013) 122 (21): 4664.

https://doi.org/10.1182/blood.V122.21.4664.4664

Published: 2013

Journal Articles

Initial Presentation Of Multiple Myeloma As Intraparenchymal Brain Mass

Ishan Malhotra, MBBS, Abhinav B. Chandra, MD, MSc, Yiwu Huang, MD, Ph.D.

Blood (2013) 122 (21): 5402.

https://doi.org/10.1182/blood.V122.21.5402.5402

Published: 2013

Journal Articles

Interim Analysis Of Zoledronic Acid and Interleukin-2 Therapy To Expand Tumoricidal γδ T Cells In Vivo In Patients With Refractory Neuroblastoma

Joseph G Pressey, MD, Adams Julia, BSN, RN, David Kelly, MD, Lawrence S. Lamb, Jr., PhD

Blood (2013) 122 (21): 2029.

https://doi.org/10.1182/blood.V122.21.2029.2029

Published: 2013

Journal Articles

CHOP-R and High-Dose Methotrexate In The Primary CNS Lymphoma Revisited. 10-Year Experience and 92 Patients From a Single Institution

Beata Ostrowska, Michal Osowiecki, Katarzyna Domanska-Czyz, Joanna Romejko-Jarosinska, Ewa Paszkiewicz-Kozik, Lidia Poplawska, Grzegorz Rymkiewicz, Jaroslaw Stobiecki, Wojciech Michalski, Jan Walewski

Blood (2013) 122 (21): 3051.

https://doi.org/10.1182/blood.V122.21.3051.3051

Published: 2013

Journal Articles

Perioperative Management Of Patients On Dabigatran – a Prospective Cohort Study

Sam Schulman, MD, PhD, James Douketis, Rebecca Barty, MLT, BA, MSc(c), Agnes Y.Y. Lee, MD, MSc, FRCPC, Marc Carrier, MD, MSc, Fred Spencer, M.D., Mark D. Blostein, M.D., Susan Solymoss, MD, Sudeep Shivakumar, MD, BSc, Grace Wang, MMath, Nancy Heddle, MSc

Blood (2013) 122 (21): 3637.

https://doi.org/10.1182/blood.V122.21.3637.3637

Published: 2013

Journal Articles

Thrombotic Thrombocytopenic Purpura Triggered by Inflammatory Pseudotumor: A Report of a Rare Case

Fernanda Loureiro de Andrade Orsi, MD, Thais Benevides, MD, Muriel S Moura, MD, Maria A Maria, MD, Priscila O. Percout, MD, Bruna m Mazetto, Margareth C Ozelo, MD, PhD, Marina Pereira Colella, MD, Erich V de Paula, MD, PhD, Joyce Annichino-Bizzachi, MD, PhD

Blood (2012) 120 (21): 4660.

https://doi.org/10.1182/blood.V120.21.4660.4660

Published: 2012

Journal Articles

Platelets Promote Ovarian Cancer Growth: New Insights On Proliferation

Minsoon Cho, Ph.D., Justin Bottsford-Miller, M.D., Behrouz Zand, M.D., Hernan G. Vasquez, Ph.D., Rebecca L. Stone, M, D., Michael H. Kroll, MD, Anil K. Sood, M.D., Vahid Afshar-Kharghan, MD

Blood (2012) 120 (21): 96.

https://doi.org/10.1182/blood.V120.21.96.96

Published: 2012

Journal Articles

CD45-CD34+ Endothelial Progenitor Cells (EPCs) from Human Adipose Tissue Promote Tumor Growth and Metastases

Patrizia Mancuso, Ines Martin Padura, Giuliana Gregato, Paola Marighetti, Angelica Calleri, Chiara Corsini, Giancarlo Pruneri, Visnu Lohsiriwat, Jean Yves Petit, Francesco Bertolini

Blood (2011) 118 (21): 2208.

https://doi.org/10.1182/blood.V118.21.2208.2208

Published: 2011

Journal Articles

Recombinant Activated Factor VII for Bleeding In the Setting of Malignancy or Hematopoietic Stem Cell Transplantation: The Australian and New Zealand Experience, 2000–2009,

Mark N Polizzotto, MBBS, BMedSc, Amanda J Zatta, BSc (Hons), PhD, Merrole F Cole-Sinclair, MBBS, BSc (Hons), Erica M Wood, MBBS, Zoe K McQuilten, MBBS, Scott Dunkley, MBBS FRACP FRCPA, Peter Cameron, MBBS, PhD, Louise E Phillips, BSc (Hons), MPH, PhD

Blood (2011) 118 (21): 3311.

https://doi.org/10.1182/blood.V118.21.3311.3311

Published: 2011

Journal Articles

Tumor-Forming Leukemia in Breast and Ovary.

Isabel Cunningham, MD

Blood (2009) 114 (22): 1014.

https://doi.org/10.1182/blood.V114.22.1014.1014

Published: 2009

Journal Articles

Intracerebellar Granulocytic Sarcoma Presenting as a First Manifestation of Relapse in Chronic Myelogenous Leukemia (CML) During Imatinib Mesylate Therapy: A Case Report and Literature Review.

Agustin Pimentel, MD, Daniel A Forman, DO, Sharon L Swierczynski, MD, PhD, Anthony A Donato, MD, Brian Le, MD

Blood (2009) 114 (22): 4289.

https://doi.org/10.1182/blood.V114.22.4289.4289

Published: 2009

Journal Articles

International Primary Central Nervous System Lymphoma Collaborative Group (IPCG) Study on Low-Grade Primary Central Nervous System Lymphoma in Immunocompetent Patients.

Agnieszka Korfel, MD, Kristoph Jahnke, MD, Brian P. O’Neill, MD, Jean-Yves Blay, MD, Lauren Abrey, MD, Peter Martus, Philip M.P. Poortmans, MD, Tamara N. Shenkier, MD, Tracy T. Batchelor, MD, Edward A. Neuwelt, MD, Jeffrey J. Raizer, MD, Hendrik Pels, MD, Ulrich Herrlinger, MD, Eckhard Thiel, MD

Blood (2005) 106 (11): 3343.

https://doi.org/10.1182/blood.V106.11.3343.3343

Published: 2005

Journal Articles

Extreme Effectiveness of Operative Resection with or without Radiotherapy as a First Line Treatment for Localized Orbital Malt Lymphoma.

Yoshihiro Yakushijin, MD, PhD, Toshio Kodama, MD, PhD, Ikue Takaoka, Masaki Otsuka, MD, Takaaki Hato, MD, PhD, Masaki Yasukawa, MD, PhD, Shigeru Fujita, MD, PhD

Blood (2004) 104 (11): 4611.

https://doi.org/10.1182/blood.V104.11.4611.4611

Published: 2004

NARROW

Development of Novel Second Generation DC/Tumor Fusion Vaccine in Lymphoma

Primary Diffuse Large B-Cell CNS Lymphoma over 80 Years: An Analysis of 110 Patients from the French Oculo-Cerebral Lymphoma (LOC) Network

Bilateral, Simultaneous Total Knee Replacement (TKR) Surgery for Hemophilia a with Eloctate (Extended Half Life Product)—A Feasible and Cost Effective Approach

Platelets Promote Activation of the Complement System in Ovarian Cancer

The French LOC Network for Primary CNS Lymphoma (PCNSL) Patients: What Can We Learn from a Large National Database?

First Report on the Safety and Efficacy of a Long-Acting Recombinant FVIII (turoctocog alfa pegol, N8-GP) during Major Surgery in Patients with Severe Hemophilia a

Levels of Circulating Alternatively Spliced Tissue Factor (asTF) in the Plasma of Patients with Pancreatic Ductal Adenocarcinoma (PDAC) May Help Predict Aggressive Tumor Phenotype

Erythrocytosis and Normal Erythropoietin Levels In a 3 Year Old Female With High-Risk Neuroblastoma

Initial Presentation Of Multiple Myeloma As Intraparenchymal Brain Mass

Interim Analysis Of Zoledronic Acid and Interleukin-2 Therapy To Expand Tumoricidal γδ T Cells In Vivo In Patients With Refractory Neuroblastoma

CHOP-R and High-Dose Methotrexate In The Primary CNS Lymphoma Revisited. 10-Year Experience and 92 Patients From a Single Institution

Perioperative Management Of Patients On Dabigatran – a Prospective Cohort Study

Thrombotic Thrombocytopenic Purpura Triggered by Inflammatory Pseudotumor: A Report of a Rare Case

Platelets Promote Ovarian Cancer Growth: New Insights On Proliferation

CD45-CD34+ Endothelial Progenitor Cells (EPCs) from Human Adipose Tissue Promote Tumor Growth and Metastases

Recombinant Activated Factor VII for Bleeding In the Setting of Malignancy or Hematopoietic Stem Cell Transplantation: The Australian and New Zealand Experience, 2000–2009,

Tumor-Forming Leukemia in Breast and Ovary.

Intracerebellar Granulocytic Sarcoma Presenting as a First Manifestation of Relapse in Chronic Myelogenous Leukemia (CML) During Imatinib Mesylate Therapy: A Case Report and Literature Review.

International Primary Central Nervous System Lymphoma Collaborative Group (IPCG) Study on Low-Grade Primary Central Nervous System Lymphoma in Immunocompetent Patients.

Extreme Effectiveness of Operative Resection with or without Radiotherapy as a First Line Treatment for Localized Orbital Malt Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only